Comparing silymarin vs NAC for liver protection during TB treatment
Treatments studied
Part of Digestive system, Infections clinical trials.
This trial tests whether two different supplements—silymarin (milk thistle) or N-acetylcysteine—can help protect the liver when given alongside standard tuberculosis treatment. It is for people newly diagnosed with TB who have not yet started medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 80 years old.
- You have been diagnosed with tuberculosis and have not started any anti-tuberculosis medicines yet.
- You do not have HIV, hepatitis B, or hepatitis C.
- You do not have serious liver disease, COPD, asthma, heart failure, kidney disease, history of stroke, or heart attack.
- You do not have a history of cancer, or conditions like rheumatoid arthritis or lupus, or alcohol use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a medicine called N-acetylcysteine (NAC) can help prevent liver damage caused by standard TB drugs. If you have a higher risk of liver injury based on your genes, you may be given NAC along with your TB treatment.
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This trial tests new combinations of TB medicines for people with active lung TB that is sensitive to standard drugs. It aims to find safer, shorter treatments that work just as well or better than current options.
Hear when a new Drug Induced Liver Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.